Aprea Therapeutics Inc. (APRE)
NASDAQ: APRE
· Real-Time Price · USD
1.71
0.02 (1.18%)
At close: Aug 15, 2025, 3:59 PM
1.67
-2.54%
After-hours: Aug 15, 2025, 07:38 PM EDT
Aprea Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 118.11K | n/a | 205.82K | 354.62K | 561.57K | 380.57K | 14.07K | 319.47K | 249.69K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 5.43K | n/a | 11.46K | n/a | 5.3K | 6.16K | 4.99K | n/a | n/a | 410.00 | n/a | 61.37K | 63.69K | 63.77K | 65.99K | 69.44K | 60.24K | 76K |
Gross Profit | 112.68K | 157.03K | 200.39K | 349.19K | 556.27K | 374.41K | 9.09K | 319.47K | 249.69K | -410 | n/a | -61.37K | -63.69K | -63.77K | -65.99K | -69.44K | -60.24K | -76K |
Operating Income | -3.39M | -4.09M | -3.23M | -4.1M | -3.85M | -3.15M | -3.67M | -3.52M | -3.65M | -4.61M | -2.62M | -4.22M | 53.42M | -8.21M | -7.75M | -9.43M | -10M | -10.19M |
Interest Income | 178.03K | 204.73K | 274.63K | 348.74K | 382.37K | 283.4K | 310.29K | 321.21K | 336.22K | 256.41K | 243.08K | 151.12K | 52.49K | n/a | 3.33K | n/a | n/a | 0.00 |
Pretax Income | -3.24M | -3.93M | -2.89M | -3.78M | -3.47M | -2.81M | -3.44M | -3.2M | -3.26M | -4.38M | -2.44M | -4.02M | -98.26M | -7.94M | -7.76M | -9.45M | -10.25M | -9.67M |
Net Income | -3.24M | -3.93M | -2.89M | -3.78M | -3.47M | -2.81M | -3.44M | -3.2M | -3.26M | -4.15M | -110.78M | -4.18M | -98.31M | -7.94M | -7.76M | -9.45M | -10.25M | -9.67M |
Selling & General & Admin | 1.59M | 1.76M | 1.07M | 1.61M | 1.85M | 1.92M | 1.64M | 1.72M | 1.7M | 3.37M | 2.12M | 3.08M | 15.63M | 3.99M | 3.37M | 3.41M | 3.34M | 3.43M |
Research & Development | 1.91M | 2.48M | 2.36M | 2.85M | 2.56M | 1.6M | 2.05M | 2.12M | 2.2M | 1.26M | 531.41K | 1.12M | 6.81M | 4.09M | 4.46M | 6.02M | 6.65M | 6.76M |
Other Expenses | n/a | n/a | -5.43K | -354.62K | n/a | n/a | n/a | -319.47K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 3.51M | 4.25M | 3.43M | 4.1M | 4.4M | 3.52M | 3.68M | 3.52M | 3.65M | 4.62M | 2.65M | 4.2M | 22.45M | 8.07M | 7.83M | 9.43M | 10M | 10.19M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 297.54K | 151.12K | 52.49K | 1.97K | 3.33K | 33.00 | 588.00 | 1.06K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | -5.3K | -6.16K | -4.99K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 3.51M | 4.25M | 3.43M | 4.1M | 4.41M | 3.53M | 3.69M | 3.52M | 3.65M | 4.62M | 2.65M | 4.2M | 22.45M | 8.07M | 7.83M | 9.43M | 10M | 10.19M |
Income Tax Expense | n/a | n/a | n/a | n/a | -5 | n/a | n/a | n/a | n/a | -229.23K | 108.34M | 151.12K | 52.49K | 1.97K | 3.33K | 21.94K | n/a | n/a |
Shares Outstanding (Basic) | 6.08M | 5.99M | 5.95M | 5.94M | 5.94M | 4.2M | 3.74M | 3.74M | 3.73M | 3.26M | 132.76K | 1.73M | 1.13M | 1.1M | 1.08M | 1.06M | 1.06M | 1.06M |
Shares Outstanding (Diluted) | 6.08M | 5.99M | 5.95M | 5.94M | 5.94M | 4.2M | 3.74M | 3.74M | 3.73M | 3.26M | 132.76K | 1.73M | 1.13M | 1.1M | 1.08M | 1.06M | 1.06M | 1.06M |
EPS (Basic) | -0.53 | -0.66 | -0.49 | -0.64 | -0.58 | -0.67 | -0.92 | -0.86 | -0.87 | -1.27 | -834.43 | -2.41 | -86.76 | -7.25 | -7.2 | -8.9 | -9.68 | -9.13 |
EPS (Diluted) | -0.53 | -0.66 | -0.49 | -0.64 | -0.58 | -0.67 | -0.92 | -0.86 | -0.87 | -1.27 | -834.43 | -2.41 | -86.76 | -7.25 | -7.2 | -8.9 | -9.68 | -9.13 |
EBITDA | -3.39M | -4.09M | -3.22M | -4.09M | -3.85M | -3.14M | -3.44M | -3.52M | -3.65M | -4.38M | -2.62M | -3.96M | -22.38M | -7.87M | -7.69M | -9.38M | -10.19M | -9.59M |
EBIT | -3.24M | -3.93M | -3.23M | -4.1M | -3.85M | -3.15M | -3.44M | -3.52M | -3.65M | -4.62M | -2.65M | -4.2M | -22.45M | -8.07M | -7.83M | -9.43M | -10M | -10.19M |
Depreciation & Amortization | n/a | 5.43K | 5.43K | 5.43K | 5.3K | 6.16K | 4.99K | 1.43K | 224.00 | 410.00 | -2.38K | 61.37K | 63.69K | 63.77K | 65.99K | 69.44K | 60.24K | 76K |